For Patients & Caregivers
Royal Jelly may benefit those with high cholesterol, but it has not been shown to treat cancer in humans.
Royal Jelly is a viscous substance secreted by the worker bees and makes up the essential food for queen bees and their larvae. It is consumed as a health food around the world. Royal jelly has been shown to lower blood pressure, lower cholesterol levels, and reduce inflammation in laboratory and animal studies. It has not been studied as a cancer treatment in humans. Royal Jelly has weak estrogenic activity and should not be used by patients with hormone-sensitive cancer.
- Menopausal symptoms
In one uncontrolled prospective study, Royal Jelly improved symptoms in postmenopausal women.
Royal Jelly improved bone health in laboratory and animal studies.
- Cholesterol management
Some research evidence supports its use for high cholesterol levels.
- Male infertility
One study suggests its use for male infertility but more large-scale clinical trials are needed to confirm this effect.
- Anecdotal weight gain, facial rash and gastrointestinal discomfort.
- Several cases of anaphylaxis, asthma, and hemorrhagic colitis have been reported with use of royal jelly.
Oral administration of high-dose royal jelly for 4 weeks was shown to adversely affect the reproductive system of pubescent male rats. The severity of these effects reduced after stopping royal jelly administration.
For Healthcare Professionals
Royal Jelly is a viscous substance secreted by worker bees and constitutes the essential food for queen bees and their larvae. It is consumed as a health food around the world. It demonstrated vasodilatory, hypotensive, antihypercholesterolemic, antitumor, anti-inflammatory, and estrogenic effects (1)(3)(9), although its affinity for estrogen receptors is weaker compared with diethylstilbestrol and phytoestrogens (3).
Royal Jelly was also shown to stimulate MCF-7 cell proliferation which was reversed by tamoxifen (3). It stimulated collagen production as well as other actions needed for bone formation via its action on osteoblasts (4).
Animal studies indicate that oral administration of Royal Jelly may be effective against colitis (10) and improve testostrerone levels in male rabbits (19).
Clinical studies have demonstrated that Royal Jelly lowered total serum lipid levels and total serum cholesterol in individuals with moderately elevated cholesterol levels (5); and improved erythropoiesis, glucose tolerance and mental health in healthy subjects (20).
Mid-cycle pericoital intravaginal applications of a combination of Egyptian bee honey and Royal Jelly improved infertility due to idiopathic asthenozoospermia (2). In an uncontrolled prospective observational study, Royal Jelly improved menopausal symptoms in postmenopausal women (6).
Because Royal Jelly has estrogenic effects, women with estrogen receptor-positive breast cancer should avoid this product; prostate cancer patients should also use caution as royal jelly increased testosterone levels in male rabbits.
Compounds identified in Royal Jelly which exhibit estrogenic activity include 1-hydroxy-trans-2-decenoic acid, 10-hydroxydecanoic acid, trans-2-decenoic acid and 24-methylenecholesterol. They inhibited the binding of estradiol to estrogen receptor beta but had little or no effects on binding to estrogen receptor alpha (4). In another study Royal Jelly stimulated the production of type 1 collagen as well as other actions needed for bone formation through its action on osteoblasts (4).
The mechanism of action for the cholesterol-lowering effects of Royal Jelly is not yet known (5). It was previously suggested that Royal Jelly decreases reabsorption of cholesterol in the GI tract and increases its excretion in the bile due to the presence of phytosterols, mainly B-sitosterol. Another explanation offered is that Royal Jelly suppresses hepatic cholesterol synthesis (8).
Royal Jelly also inhibits the growth-promoting effects of the environmental estrogen bisphenol A on human breast cancer MCF-7 cells in-vitro (7).
Oral administration of high-dose royal jelly for 4 weeks was shown to adversely affect the reproductive system of pubescent male rats. The severity of these effects reduced after cessation of administration (21).